Published in Psychopharmacology (Berl) on May 12, 2005
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A (2012) 1.79
Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) (2007) 1.60
Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology (2010) 1.39
Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry (2007) 1.36
Fatty acid-induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humans. J Clin Invest (2011) 1.01
Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging. J Pharmacol Exp Ther (2011) 1.01
The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology (Berl) (2006) 0.98
Playing it safe but losing anyway--serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion. Eur Neuropsychopharmacol (2012) 0.89
Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology (Berl) (2011) 0.89
Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition. Neuropsychopharmacology (2012) 0.88
Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology (2010) 0.88
A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment. Transl Psychiatry (2013) 0.86
Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats. Front Behav Neurosci (2011) 0.86
Contributions and complexities from the use of in vivo animal models to improve understanding of human neuroimaging signals. Front Neurosci (2014) 0.85
Escitalopram Decreases Cross-Regional Functional Connectivity within the Default-Mode Network. PLoS One (2013) 0.85
Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion. Neuroimage (2008) 0.83
Platelet serotonin transporter function predicts default-mode network activity. PLoS One (2014) 0.83
Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge. Br J Med Med Res (2012) 0.82
Systemic inflammation alters central 5-HT function as determined by pharmacological MRI. Neuroimage (2013) 0.82
Pregabalin effects on neural response to emotional faces. Front Hum Neurosci (2012) 0.81
The sum of its parts--effects of gastric distention, nutrient content and sensory stimulation on brain activation. PLoS One (2014) 0.80
Treatment with selective serotonin reuptake inhibitors and mirtapazine results in differential brain activation by visual erotic stimuli in patients with major depressive disorder. Psychiatry Investig (2009) 0.80
Neural activity changes to emotional stimuli in healthy individuals under chronic use of clomipramine. J Psychopharmacol (2009) 0.80
Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia. Int J Neuropsychopharmacol (2015) 0.79
Serotoninergic effects on judgments and social learning of trustworthiness. Psychopharmacology (Berl) (2014) 0.79
Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) (2010) 0.79
The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. BMC Psychiatry (2014) 0.79
Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants. Psychopharmacology (Berl) (2011) 0.78
Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses. J Neural Transm (Vienna) (2014) 0.78
phMRI: methodological considerations for mitigating potential confounding factors. Front Neurosci (2015) 0.77
The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. J Vis Exp (2012) 0.76
Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study. Sci Rep (2016) 0.76
Mapping glucose-mediated gut-to-brain signalling pathways in humans. Neuroimage (2014) 0.76
Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. PLoS One (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60
Validating the independent components of neuroimaging time series via clustering and visualization. Neuroimage (2004) 4.19
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry (2000) 4.03
Neuroimaging studies of mood disorders. Biol Psychiatry (2000) 3.92
Alcohol intoxication effects on simulated driving: exploring alcohol-dose effects on brain activation using functional MRI. Neuropsychopharmacology (2004) 2.12
Comparison of three methods for generating group statistical inferences from independent component analysis of functional magnetic resonance imaging data. J Magn Reson Imaging (2004) 2.03
Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology (2000) 1.43
Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage (2002) 1.31
Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials. J Clin Psychiatry (2000) 1.08
Depression and antisocial personality disorder: two contrasting disorders of 5HT function. J Neural Transm Suppl (2003) 1.08
Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology (Berl) (2001) 0.93
Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. Arch Gen Psychiatry (1988) 0.93
5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport (2002) 0.88
Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe. Neuropsychopharmacology (1996) 0.85
The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers. Psychopharmacology (Berl) (2001) 0.84
Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia. Int Clin Psychopharmacol (2000) 0.81
Distribution and characterization of [3H]mesulergine binding in human brain postmortem. Eur Neuropsychopharmacol (1999) 0.81
In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.80
Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilisation in the rat. Brain Res (1999) 0.79
Serotonin depolarizes hippocampal interneurones in the rat stratum oriens by interaction with 5HT2 receptors. Neurosci Lett (1999) 0.79
Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magn Reson Imaging (2001) 0.78
Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats. Neuroimage (2004) 0.78
Regulation of serotonin 5-HT2C receptors by chronic ligand exposure. Eur J Pharmacol (2004) 0.77
The sequence of the human genome. Science (2001) 101.55
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med (1999) 17.75
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72
Acquired resistance in Arabidopsis. Plant Cell (1992) 9.22
Movement-related effects in fMRI time-series. Magn Reson Med (1996) 8.87
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol (2003) 7.32
floricaula: a homeotic gene required for flower development in antirrhinum majus. Cell (1990) 6.52
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell (2000) 4.53
Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet (1995) 4.28
Isolation of a complementary DNA encoding a chitinase with structural homology to a bifunctional lysozyme/chitinase. Proc Natl Acad Sci U S A (1989) 4.00
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95
Palliative and end-of-life care in the African American community. JAMA (2000) 3.62
The dendritic cell populations of mouse lymph nodes. J Immunol (2001) 3.57
Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci (2000) 3.49
Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem (1990) 3.25
Endoscopic sphincterotomy in 1000 consecutive patients. Lancet (1989) 3.20
The emerging role of the emergency care practitioner. Emerg Med J (2004) 2.95
Reducing work related psychological ill health and sickness absence: a systematic literature review. Occup Environ Med (2003) 2.88
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
Intravenous or inhaled salbutamol in severe acute asthma? Thorax (1977) 2.82
Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl) (2002) 2.77
Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol (1996) 2.70
CpG island clones from a deletion encompassing the gene for adenomatous polyposis coli. Proc Natl Acad Sci U S A (1989) 2.66
Complexity- and risk-adjusted model for measuring surgical outcome. Br J Surg (1999) 2.62
Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med (1995) 2.55
Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J (1999) 2.50
Response inhibition and impulsivity: an fMRI study. Neuropsychologia (2003) 2.45
Evaluation of four DNA typing techniques in epidemiological investigations of bovine tuberculosis. J Clin Microbiol (1998) 2.44
DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry (1987) 2.40
Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology (1989) 2.37
Rapid construction of large synthetic genes: total chemical synthesis of two different versions of the bovine prochymosin gene. Gene (1987) 2.36
The influence of vector behavior on malaria transmission. Am J Trop Med Hyg (1972) 2.34
Survey of plasmids and resistance factors in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1985) 2.27
Psychometric properties of the Centre for Epidemiologic Studies Depression Scale (CES-D) in a sample of women in middle life. Behav Res Ther (1997) 2.17
The MHC haplotype project: a resource for HLA-linked association studies. Tissue Antigens (2002) 2.16
ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem (1997) 2.15
How soon after myocardial infarction should plasma lipid values be assessed? Br Med J (Clin Res Ed) (1984) 2.10
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med (2000) 2.10
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. Proc Natl Acad Sci U S A (2007) 2.10
The value, qualification, and regulatory use of surrogate end points in drug development. Clin Pharmacol Ther (2009) 2.08
Respiratory arrest following intrathecal injection of sufentanil and bupivacaine in a parturient. Can J Anaesth (1998) 2.07
A method to estimate prevalence of iron deficiency and iron deficiency anemia in adolescent Jamaican girls. Am J Clin Nutr (1997) 2.05
Randomised controlled trial of effect of fruit and vegetable consumption on plasma concentrations of lipids and antioxidants. BMJ (1997) 2.04
Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Hum Brain Mapp (2000) 2.04
Written informed consent in patients with breast cancer. Cancer (1979) 2.01
The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci (1998) 2.01
The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand. N Z Med J (1994) 1.99
Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood (1996) 1.98
How good is good enough in path analysis of fMRI data? Neuroimage (2000) 1.92
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocr Relat Cancer (2004) 1.91
Radiation exposure to the spine surgeon during fluoroscopically assisted pedicle screw insertion. Spine (Phila Pa 1976) (2000) 1.91
Stachybotrys, a mycotoxin-producing fungus of increasing toxicologic importance. J Toxicol Clin Toxicol (1998) 1.91
Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry (2001) 1.89
Socio-economic inequalities in diabetes complications, control, attitudes and health service use: a cross-sectional study. Diabet Med (2003) 1.88
Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1992) 1.88
Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med (1991) 1.85
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis (2008) 1.84
Limb salvage surgery for pathological fractures in osteosarcoma. Int Orthop (2000) 1.82
Regulation of pathogenesis-related protein-1a gene expression in tobacco. Plant Cell (1993) 1.81
Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs (1999) 1.78
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract (2000) 1.74
Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J Biol Chem (1991) 1.74
Do nursing home residents make greater demands on GPs? A prospective comparative study. Br J Gen Pract (1999) 1.73
DSM-III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry (1990) 1.73
Rapid detection and identification of respiratory viruses by direct immunofluorescence. Appl Microbiol (1970) 1.73
Cloning and characterization of the aldA gene of Aspergillus nidulans. Gene (1987) 1.70
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70
Evaluating the influence of implicit models of mental disorder on processes of shared decision making within community-based multi-disciplinary teams. Soc Sci Med (2003) 1.69
Predictors of re-employment and quality of life in NHS staff one year after early retirement because of ill health; a national prospective study. Occup Environ Med (2004) 1.69
Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol (1999) 1.67
Computer assisted assessment and advice for "non-serious" 999 ambulance service callers: the potential impact on ambulance despatch. Emerg Med J (2003) 1.66
Dying from cancer in community hospitals or a hospice: closest lay carers' perceptions. Br J Gen Pract (1998) 1.66
Fast events in protein folding: relaxation dynamics of secondary and tertiary structure in native apomyoglobin. Proc Natl Acad Sci U S A (1997) 1.65
Characteristics of patients registered for service at a neighborhood health center. Am J Public Health Nations Health (1970) 1.65
Are life events related to the onset of breast cancer. Psychol Med (1996) 1.64
Effects of quinolinic acid-induced lesions of the orbital prefrontal cortex on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl) (2002) 1.62
Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol (1999) 1.62
Audiometric notch as a sign of noise induced hearing loss. Occup Environ Med (2001) 1.62
SLACS retrotransposon from Trypanosoma brucei gambiense is similar to mammalian LINEs. Nucleic Acids Res (1990) 1.62
DSM-III disorders from age 11 to age 15 years. J Am Acad Child Adolesc Psychiatry (1992) 1.61
Prevalence and numbers of Salmonella and Campylobacter spp. on raw, whole chickens in relation to sampling methods. Int J Food Microbiol (2002) 1.60
Discover diabetes: a community based screening programme for diabetic eye disease. N Z Med J (1994) 1.60
Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems. Eur J Neurosci (2005) 1.60
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am (2000) 1.57
Controlled trial of fetal intensive care. Am J Obstet Gynecol (1976) 1.57
Hallucinations in nonpsychotic children. J Am Acad Child Adolesc Psychiatry (2000) 1.57
Utilization of psychotherapy research by practicing psychotherapists. Am Psychol (1986) 1.55
A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction (2000) 1.55
Depression and the development of cancer: a meta-analysis. Soc Sci Med (1994) 1.55
Rilpivirine versus efavirenz in HIV-1-infected subjects receiving emtricitabine/tenofovir DF: pooled 96-week data from ECHO and THRIVE Studies. HIV Clin Trials (2013) 1.53
Relationships of changes in craniofacial morphology, head posture, and nasopharyngeal airway size following mandibular osteotomy. Am J Orthod Dentofacial Orthop (1989) 1.53
Non-invasive detection of hypoglycaemia using a novel, fully biocompatible and patient friendly alarm system. BMJ (2001) 1.53
A longitudinal study of children with developmental language delay at age three: later intelligence, reading and behaviour problems. Dev Med Child Neurol (1987) 1.52